Novel Compound Cytokine Release Inhibitory Drug 3 (CRID3) Inhibits the NLRP3 Inflammasome in Rheumatoid Arthritis

T. McGarry, M. Connolly, R. C. Coll, A. A. B. Robertson, M. A. Cooper, L. A. O'Neill, D. J. Veale, U. Fearon

Research output: Contribution to journalMeeting abstract

Cite this

McGarry, T., Connolly, M., Coll, R. C., Robertson, A. A. B., Cooper, M. A., O'Neill, L. A., Veale, D. J., & Fearon, U. (2014). Novel Compound Cytokine Release Inhibitory Drug 3 (CRID3) Inhibits the NLRP3 Inflammasome in Rheumatoid Arthritis. Arthritis and Rheumatology.